Skip to main content
. 2021 Jan 22;20(1):90–100. doi: 10.5217/ir.2020.00133

Fig. 3.

Fig. 3.

Cumulative surgery-free rate without change of therapy for 60 months in Crohn’s disease patients with NUDT15 C/C and C/T genotypes. The patients were treated with combination therapy (thiopurine+anti-tumor necrosis factor-α agent).